Skip to content

A Study of the Sense of Smell in Relatives of Parkinson's Disease Patients

Screening Evaluations for Neurologic Syndromes: Olfactory Testing in Relatives of Parkinson's Disease Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00096876
Enrollment
600
Registered
2004-11-17
Start date
2004-10-31
Completion date
2008-06-30
Last updated
2019-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease, Parkinsonian Syndrome

Keywords

Parkinsonian syndrome

Brief summary

In this study, individuals complete and return a mail survey, specifically a 40 item scratch and sniff smell test.

Detailed description

This study would extend the findings of previous studies by characterizing the performance of the 40-item UPSIT in a cohort of first-degree relatives of Parkinson's disease (PD) patients. The results would also validate the use of the University of Pennsylvania Smell Identification Test (UPSIT) as a mail-survey instrument. Once identified, these individuals could be followed as a potentially at-risk cohort to determine if the screening evaluation was predictive of later developing Parkinson's disease. The results from this pilot study have the potential to guide the use of olfactory testing using the UPSIT as a screening tool, and to provide necessary preliminary data for planning clinical trials to prevent the occurrence of PD in at-risk individuals.

Interventions

None listed

Sponsors

Institute for Neurodegenerative Disorders
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subject must be a first-degree relative of a PD patient with diagnosis confirmed by a movement disorders specialist at the Institute for Neurodegenerative Disorders * Subject must not carry a diagnosis of PD or other neurodegenerative disorder * Subject must be either at least 50 years old or within 10 years of the age of onset of their affected relative * Subject must be a non-smoker * Subject must have no other known reason for abnormal olfaction (e.g. nasal trauma)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026